Rare diseases
Investigational molecules
Locations
Back to the United States1 clinical trial in Levice, United States. Every trial is listed in the EU Clinical Trials Register and updated daily.
United StatesThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on COPD treatments, evaluating novel therapies like tezepelumab and combination inhalers for managing moderate to severe cases. Studies aim to reduce exacerbations and improve lung function.
Multiple trials investigating innovative approaches to prevent disease progression and enhance quality of life.
Breakthrough investigations into uncontrolled asthma treatments, including studies of novel compounds like AZD8630 and atuliflapon. Research focuses on preventing lung function decline and managing severe cases.
Advanced therapeutic approaches being tested to address treatment-resistant cases.
Innovative research examining stroke prevention and treatment, including studies of new anticoagulants like asundexian and milvexian. Additional focus on cardiovascular outcomes in patients with end-stage kidney disease.
Comprehensive evaluation of new therapeutic options for better patient outcomes.
Clinical investigations into chronic spontaneous urticaria treatment, focusing on long-term efficacy and safety of remibrutinib for patients with persistent symptoms.
Innovative approaches to managing chronic skin conditions with novel therapeutic agents.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
